Siteman Cancer Center - St. Peters is a clinical research site located in City of Saint Peters, Missouri, United States 63376.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Siteman Cancer Center - St. Peters has participated in 11 clinical trials with 3 currently active.
Therapeutic areas: Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Takeda.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Siteman Cancer Center - St. Peters has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Siteman Cancer Center - St. Peters has 11 clinical trials on record, with 3 currently active. Their work covers Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse.
Yes — Siteman Cancer Center - St. Peters holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.